𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Causes and consequences of 93 fetuses with cardiomegaly in a tertiary center in Thailand

✍ Scribed by Piyawadee Wuttikonsammakit; Boonchai Uerpairojkit; Somchai Tanawattanacharoen


Publisher
Springer
Year
2010
Tongue
English
Weight
244 KB
Volume
283
Category
Article
ISSN
0003-9128

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Predictors of adalimumab dose escalation
✍ Russell D. Cohen; Jeffrey R. Lewis; Hannah Turner; Laura E. Harrell; Stephen B. πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 167 KB πŸ‘ 2 views

Background: Pivotal trials for adalimumab (ADA) demonstrated effectiveness versus placebo for induction and maintenance of remission in moderate to severely active Crohn's disease (CD). Although the approved maintenance regimen in the U.S. is 40 mg subcutaneously every 14 days, some patients require